MolecuLight Featured in 11 Presentations and Posters at European Wound Management Association (EWMA) 2024 Annual Conference

May 2, 2024 -Wide-Spread Clinical Evidence using the MolecuLight Imaging Platform Reveals its Significant Global Adoption and Proven Utility in Wound Care

Toronto, CANADA and London, UK – (May 1, 2024) – MolecuLight Corp., the leader in point-of-care digital wound measurement and real-time bacterial detection through fluorescence imaging, announces that its MolecuLight wound imaging

Read More

MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs

January 25, 2024 -New Contract Expands VA Wound Care Center Access to MolecuLight i:X® and DX™ Point-of-Care Devices that Help Clinicians Manage Infection and Improve Outcomes

Pittsburgh, PA – January25, 2024 – MolecuLight Corp., the leader in point-of-care bacterial fluorescence imaging, announced today that the US Department of Veterans Affairs has awarded MolecuLight a

Read More

MolecuLight Successfully Completes SOC 2 Type II Audit

December 12, 2023 -The company’s compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security

TORONTO, ON – (December 12, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated bacterial loads in and around wounds, announces

Read More

Latest Clinical Evidence Presented at APWCA’s Wound Week™ 2023 Illustrates the Significant and New Clinical Utility

September 21, 2023 -6 Clinical Posters and a Presentation Including New Results of a 1,447 Patient Study Highlights the Breadth of Clinical Benefits of the MolecuLight Device for Wound Care Applications

Toronto, ONTARIO and Philadelphia, PENNSYLVANIA – (September 21, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of

Read More

Largest Published Real-World Wound Imaging Study Reports MolecuLight® led to Wound Treatment Plan Changes in up to 53% Cases

May 23, 2023 -Results from 211 Facilities Show MolecuLight Imaging is a Valuable Tool in Improving Bacterial Infection Management

TORONTO, ON – (May 23, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated, pathogenic bacterial loads in and around wounds, announced the publication of their latest publication,

Read More

MolecuLight Featured in Unprecedented 24 Presentations and Posters at European Wound Management Association (EWMA) 2023 Annual Conference

May 3, 2023 -Wide-Spread Clinical Evidence using the MolecuLight Imaging Platform Revealsits Significant Global Adoption and Proven Utility in Wound Care

Toronto, CANADA and Milan, ITALY – (May 3, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that detects and locates elevated bacterial loads in wounds, announces that its MolecuLight wound

Read More

Previous